These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 14693160)
1. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Broudy VC; Lin NL Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160 [TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673 [TBL] [Abstract][Full Text] [Related]
3. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies. Millot GA; Vainchenker W; Duménil D; Svinarchuk F Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665 [TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811 [TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921 [TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823 [TBL] [Abstract][Full Text] [Related]
8. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812 [TBL] [Abstract][Full Text] [Related]
9. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways. Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319 [TBL] [Abstract][Full Text] [Related]
10. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e. Quentmeier H; Zaborski M; Drexler HG Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506 [TBL] [Abstract][Full Text] [Related]
11. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl. Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143 [TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3. Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303 [TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin and its receptor. Wendling F; Vainchenker W Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170 [TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line. Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467 [TBL] [Abstract][Full Text] [Related]
15. A novel MPL point mutation resulting in thrombopoietin-independent activation. Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691 [TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464 [TBL] [Abstract][Full Text] [Related]
17. Signal transduction by the peptide which mimics the activity of thrombopoietin. Kimura T; Kaburaki H; Tsujino T; Watanabe Y; Kato H Biochem Mol Biol Int; 1998 May; 44(6):1203-9. PubMed ID: 9623775 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Broudy VC; Lin NL; Kaushansky K Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585 [TBL] [Abstract][Full Text] [Related]
20. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain. Drachman JG; Kaushansky K Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]